Cue Biopharma, Inc. - 8-K Filing

Cue Biopharma announced the resignation of four board members—Jill Broadfoot, Peter Kiener, Frank Morich, and Patrick Verheyen—and appointed two new directors: Daniel Camardo and Viola Meehan. The company also named Sumita Ray as Chief Legal & Compliance Officer and Corporate Secretary, replacing Colin Sandercock who will remain in an IP role, and promoted Michael Meluzio to Vice President and Principal Accounting Officer. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 8.01 Other Events)

SEC EDGAR ·

Tickers: $CUE

Read the full article at SEC EDGAR

More Regulatory news